Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-09

Clinical Trial Update: Abobotulinum Toxin and Neubotulinum Toxin Injection in Cerivical Dystonia [Phase 3]

View source ↗

Summary

Phase 3 trial update for abobotulinum toxin and neubotulinum toxin injections in cervical dystonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abobotulinum Toxin (abobotulinum toxin type A)
  • Neubotulinum Toxin

Snippet

Sponsor: Department of Medical Services Ministry of Public Health of Thailand | Conditions: Cervical Dystonia | Phase 3 | Status: COMPLETED